89 related articles for article (PubMed ID: 31394699)
1. Metastasis Promoter S100A4 is a Potential Molecular Therapeutic Target.
Sherbet GV
Cancer Genomics Proteomics; 2006; 3(3-4):203-216. PubMed ID: 31394699
[TBL] [Abstract][Full Text] [Related]
2. Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy.
Sherbet GV
Cancer Lett; 2009 Jul; 280(1):15-30. PubMed ID: 19059703
[TBL] [Abstract][Full Text] [Related]
3. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF.
Jia W; Gao XJ; Zhang ZD; Yang ZX; Zhang G
Eur Rev Med Pharmacol Sci; 2013 Jun; 17(11):1495-508. PubMed ID: 23771538
[TBL] [Abstract][Full Text] [Related]
4. S100A4 (MTS1) calcium binding protein in cancer growth, invasion and metastasis.
Sherbet GV; Lakshmi MS
Anticancer Res; 1998; 18(4A):2415-21. PubMed ID: 9703888
[TBL] [Abstract][Full Text] [Related]
5. Blocking TGF-β inhibits breast cancer cell invasiveness via ERK/S100A4 signal.
Wang XG; Meng Q; Qi FM; Yang QF
Eur Rev Med Pharmacol Sci; 2014; 18(24):3844-53. PubMed ID: 25555875
[TBL] [Abstract][Full Text] [Related]
6. Interaction of extracellular S100A4 with RAGE prompts prometastatic activation of A375 melanoma cells.
Herwig N; Belter B; Wolf S; Haase-Kohn C; Pietzsch J
J Cell Mol Med; 2016 May; 20(5):825-35. PubMed ID: 26928771
[TBL] [Abstract][Full Text] [Related]
7. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13.
Wang L; Wang X; Liang Y; Diao X; Chen Q
Acta Biochim Pol; 2012; 59(4):593-8. PubMed ID: 23162804
[TBL] [Abstract][Full Text] [Related]
8. S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma.
Zou M; Al-Baradie RS; Al-Hindi H; Farid NR; Shi Y
Br J Cancer; 2005 Nov; 93(11):1277-84. PubMed ID: 16265347
[TBL] [Abstract][Full Text] [Related]
9. S100A4 in cancer progression and metastasis: A systematic review.
Fei F; Qu J; Zhang M; Li Y; Zhang S
Oncotarget; 2017 Sep; 8(42):73219-73239. PubMed ID: 29069865
[TBL] [Abstract][Full Text] [Related]
10. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
Zhao Y; Zhang T; Wang Q
Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis.
Berge G; Pettersen S; Grotterød I; Bettum IJ; Boye K; Mælandsmo GM
Int J Cancer; 2011 Aug; 129(4):780-90. PubMed ID: 20957651
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of plasma and tissue S100A4 protein and mRNA levels as potential markers of metastasis and prognosis in clear cell renal cell carcinoma.
Yang H; Zhao K; Yu Q; Wang X; Song Y; Li R
J Int Med Res; 2012; 40(2):475-85. PubMed ID: 22613408
[TBL] [Abstract][Full Text] [Related]
13. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
Zhang J; Zhang DL; Jiao XL; Dong Q
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
[TBL] [Abstract][Full Text] [Related]
14. Extracellular S100A4 as a key player in fibrotic diseases.
Li Z; Li Y; Liu S; Qin Z
J Cell Mol Med; 2020 Jun; 24(11):5973-5983. PubMed ID: 32307910
[TBL] [Abstract][Full Text] [Related]
15. S100A4 and its role in metastasis – simulations of knockout and amplification of epithelial growth factor receptor and matrix metalloproteinases.
Buetti-Dinh A; Pivkin IV; Friedman R
Mol Biosyst; 2015 Aug; 11(8):2247-54. PubMed ID: 26057862
[TBL] [Abstract][Full Text] [Related]
16. The metastasis associated protein S100A4: a potential novel link to inflammation and consequent aggressive behaviour of rheumatoid arthritis synovial fibroblasts.
Oslejsková L; Grigorian M; Gay S; Neidhart M; Senolt L
Ann Rheum Dis; 2008 Nov; 67(11):1499-504. PubMed ID: 18056757
[TBL] [Abstract][Full Text] [Related]
17. The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer.
Stein U; Arlt F; Walther W; Smith J; Waldman T; Harris ED; Mertins SD; Heizmann CW; Allard D; Birchmeier W; Schlag PM; Shoemaker RH
Gastroenterology; 2006 Nov; 131(5):1486-500. PubMed ID: 17101323
[TBL] [Abstract][Full Text] [Related]
18. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
19. The Multifaceted S100A4 Protein in Cancer and Inflammation.
Ambartsumian N; Klingelhöfer J; Grigorian M
Methods Mol Biol; 2019; 1929():339-365. PubMed ID: 30710284
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: role of the S100A4-miR155-SOCS1-MMP9 axis.
Yan XL; Jia YL; Chen L; Zeng Q; Zhou JN; Fu CJ; Chen HX; Yuan HF; Li ZW; Shi L; Xu YC; Wang JX; Zhang XM; He LJ; Zhai C; Yue W; Pei XT
Hepatology; 2013 Jun; 57(6):2274-86. PubMed ID: 23316018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
